1)Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004; 20: 781-810
|
|
|
2)MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and dis-eases. Dev Cell. 2009; 17: 9-26
|
|
|
3)Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell. 2012; 149: 1192-205
|
|
|
4)Kimura KD, Tissenbaum HA, Liu Y, et al. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science. 1997; 277: 942-6
|
|
|
5)Liu H, Fergusson MM, Castilho RM, et al. Augmented Wnt signaling in a mammalian model of accelerated aging. Science. 2007; 317: 803-6
|
|
|
6)Kurosu H, Yamamoto M, Clark JD, et al. Suppression of aging in mice by the hormone Klotho. Science. 2005; 309: 1829-33
|
|
|
7)Urakawa I, Yamazaki Y, Shimada T, et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature. 2006; 444: 770-4
|
|
|
8)Brack AS, Conboy MJ, Roy S, et al. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science. 2007; 317: 807-10
|
|
|
9)Villeda SA, Luo J, Mosher KI, et al. The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature. 2011; 477: 90-4
|
|
|
10)Loffredo FS, Steinhauser ML, Jay SM, et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013; 153: 828-39
|
|
|
11)Naito AT, Sumida T, Nomura S, et al. Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes. Cell. 2012; 149: 1298-313
|
|
|
12)Lachmann PJ, Hughes-Jones NC. Initiation of complement activation. Springer Semin Immunopathol. 1984; 7: 143-62
|
|
|
13)Liu G, Bafico A, Harris VK, et al. A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptor. Mol Cell Biol. 2003; 23: 5825-35
|
|
|
14)Walport MJ. Complement. First of two parts. N Engl J Med. 2001; 344: 1058-66
|
|
|
15)Velazquez P, Cribbs DH, Poulos TL, et al. Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimerʼs disease pathogenesis. Nat Med. 1997; 3: 77-9
|
|
|
16)Okroj M, Heinegard D, Holmdahl R, et al. Rheumatoid arthritis and the complement system. Ann Med. 2007; 39: 517-30
|
|
|
17)Nakatsuji H, Kobayashi H, Kishida K, et al. Binding of adiponectin and C1q in human serum, and clinical significance of the measurement of C1q-adiponectin / total adiponectin ratio. Metabolism. 2012; 62: 109-20
|
|
|
18)Yamada Y, Ando F, Shimokata, H. Association of polymorphisms of SORBS1, GCK and WISP1 with hypertension in community-dwelling Japanese individuals. Hypertens Res. 2009; 32: 325-31
|
|
|
19)Ye X, Zerlanko B, Kennedy A, et al. Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells. Mol Cell. 2007; 27: 183-96
|
|
|
20)Espada J, Varela I, Flores I, et al. Nuclear envelope defects cause stem cell dysfunction in premature-aging mice. J Cell Biol. 2008; 181: 27-35
|
|
|